Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Apr-22 9:34 PM View:  | Theravance Biopharma, Inc. (TBPH) | 26-Apr-22 | Grant | 9,852 | -- | -- | 14% 68.16K to 78.01K | |
| 07-Jul-21 5:16 PM View: | Praxis Precision Medicines,... (PRAX) | 13-May-21 | Acquisition (other) | 28,473 | -- | -- | 100% 0 to 28.47K | |
| 29-Apr-21 6:14 PM View: | Theravance Biopharma, Inc. (TBPH) | 27-Apr-21 | Grant | 9,828 | -- | -- | 17% 58.33K to 68.16K | |
| 30-Apr-20 7:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 28-Apr-20 | Grant | 6,635 | -- | -- | 13% 51.7K to 58.33K | |
| 06-Jan-20 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Jan-20 | Option Exercise | 20,000 | $72.14 | $1,442,800.00 | 215% 9.31K to 29.31K | |
| 06-Jan-20 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Jan-20 | Planned Option Sale | 20,000 | $218.93 | $4,378,700.00 | (68%) 29.31K to 9.31K | |
| 02-Jan-20 4:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Dec-19 | Option Exercise | 30,000 | $65.65 | $1,969,500.00 | 322% 9.31K to 39.31K | |
| 02-Jan-20 4:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Dec-19 | Planned Option Sale | 30,000 | $218.76 | $6,562,720.00 | (76%) 39.31K to 9.31K | |
| 04-Jun-19 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-19 | Grant | 2,381 | -- | -- | 34% 6.93K to 9.31K | |
| 02-May-19 6:36 PM View: | Theravance Biopharma, Inc. (TBPH) | 30-Apr-19 | Grant | 8,385 | -- | -- | 19% 43.31K to 51.7K | |
| 05-Jun-18 4:30 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-18 | Grant | 1,801 | -- | -- | 35% 5.13K to 6.93K | |
| 03-May-18 6:20 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-May-18 | Grant | 8,186 | -- | -- | 23% 35.12K to 43.31K | |
| 05-Jun-17 6:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-17 | Grant | 2,188 | -- | -- | 74% 2.94K to 5.13K | |
| 18-May-17 6:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 17-May-17 | Grant | 6,000 | -- | -- | 21% 29.12K to 35.12K | |
| 03-Jun-16 5:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-16 | Grant | 2,941 | $0.01 | $29.41 | 100% 0 to 2.94K | |
| 05-May-16 7:15 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-May-16 | Grant | 6,000 | -- | -- | 26% 23.12K to 29.12K | |
| 18-Jun-15 4:35 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 10-Jun-15 | Grant | 1,100 | -- | -- | 10% 10.78K to 11.88K | |
| 24-Apr-15 6:58 PM View: | Theravance Biopharma, Inc. (TBPH) | 22-Apr-15 | Grant | 6,000 | -- | -- | 35% 17.12K to 23.12K | |
| 06-Jun-14 6:47 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 04-Jun-14 | Grant | 2,100 | -- | -- | 24% 8.68K to 10.78K | |
| 27-May-14 7:16 PM View: | Theravance Inc. (INVA) | 22-May-14 | Grant | 6,000 | -- | -- | 8% 77.94K to 83.94K | |
| 09-Apr-14 7:07 PM View: | Theravance Inc. (INVA) | 07-Apr-14 | Option Exercise | 25,806 | $9.69 | $249,996.00 | 50% 52.13K to 77.94K | |
| 17-May-13 7:21 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-May-13 | Grant | 3,400 | -- | -- | 64% 5.28K to 8.68K | |
| 26-Apr-13 7:04 PM View: | Theravance Inc. (INVA) | 24-Apr-13 | Grant | 6,000 | -- | -- | 13% 46.13K to 52.13K | |
| 17-May-12 7:07 PM View: | Theravance Inc. (INVA) | 15-May-12 | Grant | 6,000 | -- | -- | 15% 40.13K to 46.13K | |
| 10-May-12 5:33 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 08-May-12 | Grant | 3,400 | -- | -- | 181% 1.88K to 5.28K | |
| 16-May-11 7:00 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 12-May-11 | Grant | 1,875 | -- | -- | 100% 0 to 1.88K | |
| 28-Apr-11 7:18 PM View: | Theravance Inc. (INVA) | 27-Apr-11 | Grant | 6,000 | -- | -- | 18% 34.13K to 40.13K | |
| 09-Mar-11 7:00 PM View: | Theravance Inc. (INVA) | 07-Mar-11 | Option Exercise | 10,752 | $8.52 | $91,660.80 | 37% 28.75K to 39.51K | |
| 09-Mar-11 7:00 PM View: | Theravance Inc. (INVA) | 07-Mar-11 | Market Option Sale | 5,376 | $22.31 | $119,939.00 | (14%) 39.51K to 34.13K | 40% |
| 23-Feb-11 7:04 PM View: | Theravance Inc. (INVA) | 18-Feb-11 | Option Exercise | 10,752 | $8.52 | $91,660.80 | 46% 23.38K to 34.13K | |
| 23-Feb-11 7:04 PM View: | Theravance Inc. (INVA) | 18-Feb-11 | Market Option Sale | 5,376 | $23.22 | $124,831.00 | (16%) 34.13K to 28.75K | 42% |
| 13-Dec-10 7:06 PM View: | Theravance Inc. (INVA) | 10-Dec-10 | Option Exercise | 10,754 | $8.52 | $91,677.80 | 60% 18.0K to 28.75K | |
| 13-Dec-10 7:06 PM View: | Theravance Inc. (INVA) | 10-Dec-10 | Market Option Sale | 5,377 | $26.64 | $143,243.00 | (19%) 28.75K to 23.38K | 49% |
| 28-Apr-10 7:06 PM View: | Theravance Inc. (INVA) | 27-Apr-10 | Grant | 6,000 | -- | -- | 50% 12.0K to 18.0K | |
| 24-Apr-09 7:14 PM View: | Theravance Inc. (INVA) | 24-Apr-09 | Grant | 6,000 | -- | -- | 100% 6.0K to 12.0K | |
| 13-May-08 6:53 PM View: | Monogram Biosciences, Inc. (MGRMD) | 09-May-08 | Market Purchase | 100,000 | $1.06 | $105,549.00 | 38% 261.81K to 361.81K | (58%) |
| 24-Apr-08 7:44 PM View: | Theravance Inc. (INVA) | 22-Apr-08 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 09-Aug-05 4:14 PM View: | Monogram Biosciences, Inc. (MGRMD) | 05-Aug-05 | Market Purchase | 25,000 | $2.37 | $59,158.00 | 12% 202.56K to 227.56K | (81%) |